BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15718130)

  • 21. Protein-protein interactions: mechanisms and modification by drugs.
    Veselovsky AV; Ivanov YD; Ivanov AS; Archakov AI; Lewi P; Janssen P
    J Mol Recognit; 2002; 15(6):405-22. PubMed ID: 12501160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent applications of protein crystallography and structure-guided drug design.
    Williams SP; Kuyper LF; Pearce KH
    Curr Opin Chem Biol; 2005 Aug; 9(4):371-80. PubMed ID: 16006182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoinhibited proteins as promising drug targets.
    Peterson JR; Golemis EA
    J Cell Biochem; 2004 Sep; 93(1):68-73. PubMed ID: 15352163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FISH and immunocytochemistry: towards visualising single target molecules in living cells.
    Tanke HJ; Dirks RW; Raap T
    Curr Opin Biotechnol; 2005 Feb; 16(1):49-54. PubMed ID: 15722015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery.
    Pierceall WE; Zhang L; Hughes DE
    Methods Mol Biol; 2004; 261():187-98. PubMed ID: 15064459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered affinity proteins--generation and applications.
    Grönwall C; Ståhl S
    J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
    Block P; Weskamp N; Wolf A; Klebe G
    Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides mediating interaction networks: new leads at last.
    Neduva V; Russell RB
    Curr Opin Biotechnol; 2006 Oct; 17(5):465-71. PubMed ID: 16962311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of tools for protein phosphorylation site analysis: from discovery to clinical application.
    Bonilla L; Means G; Lee K; Patterson S
    Biotechniques; 2008 Apr; 44(5):671-9. PubMed ID: 18474044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs targeting protein-protein interactions.
    Chène P
    ChemMedChem; 2006 Apr; 1(4):400-11. PubMed ID: 16892375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein surface recognition and proteomimetics: mimics of protein surface structure and function.
    Fletcher S; Hamilton AD
    Curr Opin Chem Biol; 2005 Dec; 9(6):632-8. PubMed ID: 16242379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database.
    Higueruelo AP; Schreyer A; Bickerton GR; Pitt WR; Groom CR; Blundell TL
    Chem Biol Drug Des; 2009 Nov; 74(5):457-67. PubMed ID: 19811506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational drug design via intrinsically disordered protein.
    Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
    Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of protein-protein interactions with small organic molecules.
    Berg T
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2462-81. PubMed ID: 12800163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface grafting onto template-assembled synthetic protein scaffolds in molecular recognition.
    Fernandez-Carneado J; Grell D; Durieux P; Hauert J; Kovacsovics T; Tuchscherer G
    Biopolymers; 2000; 55(6):451-8. PubMed ID: 11304672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.